Fox Run Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
30,223
+13,914
+85% +$561K 0.21% 110
2026
Q1
$528K Buy
16,309
+10,013
+159% +$419K 0.09% 407
2025
Q4
$285K Sell
6,296
-9,392
-60% -$344K 0.04% 712
2025
Q3
$478K Sell
15,688
-728
-4% -$22.4K 0.07% 510
2025
Q2
$483K Buy
16,416
+3,601
+28% +$108K 0.08% 480
2025
Q1
$448K Buy
+12,815
New +$508K 0.07% 533
2024
Q4
Sell
-5,578
Closed -$243K 1094
2024
Q3
$243K Buy
+5,578
New +$210K 0.05% 616
2024
Q2
Sell
-7,088
Closed -$207K 990
2024
Q1
$207K Sell
7,088
-374
-5% -$11.3K 0.04% 624
2023
Q4
$281K Buy
+7,462
New +$274K 0.07% 516
2019
Q2
Sell
-4,575
Closed -$370K 572
2019
Q1
$370K Sell
4,575
-1,504
-25% -$113K 0.21% 198
2018
Q4
$372K Buy
+6,079
New +$412K 0.2% 203

Other funds holding OMCL

Fox Run Management's OMCL Position: Q2 2026 in Review

Fox Run Management increased its Omnicell (OMCL) stake by 85% in Q2 2026, buying an estimated $561K and bringing the position to 30,223 shares worth $1.25M. The position accounts for 0.21% of the portfolio, ranked #110.

Fox Run Management first reported a position in OMCL in Q4 2018 and has held it in 11 quarters since. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Fox Run Management held 30,223 shares of Omnicell worth $1.25M as of Q2 2026.
  • Fox Run Management bought 13,914 Omnicell shares in Q2 2026, an estimated $561K.
  • Omnicell made up 0.21% of Fox Run Management's portfolio in Q2 2026, its #110 holding.
  • Fox Run Management first reported a position in Omnicell in Q4 2018 and has held it in 11 quarters since.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.